Literature DB >> 34350694

The Sustainability of Energy Conversion Inhibition for Tumor Ferroptosis Therapy and Chemotherapy.

Wei Jiang1, Xingyu Luo1, Lulu Wei2, Shanmei Yuan3, Jianfeng Cai2, Xiqun Jiang4, Yong Hu1.   

Abstract

The hyperactive energy metabolism mostly contributes the tumor cells growth and proliferation. Herein, the intelligent nanoparticles (P-B-D NPs) obtained by loading BAY-876 and doxorubicin (Dox)-Duplex into nanoparticles composed of disulfide bond (SS) containing polymer are reported, which provide an efficient resistance of tumor cells energy metabolism and tumor growth to conquer malignant tumor. In response to the reducing microenvironment of tumor tissue, the SS bond can be disintegrated by intracellular glutathione to block the synthesis of lipid repair enzyme-glutathione peroxidase 4 for ferroptosis therapy. More importantly, the released BAY-876 can inhibit the functionality of glucose transporter 1, restricting the glucose uptake of tumor cells to a low energy metabolism status. Meanwhile, Dox-Duplex can interact with ATP to reduce intracellular ATP content and release Dox to kill tumor cells. Collectively, this work offers a new idea for restricting tumor cells energy metabolism to inhibit their proliferation.
© 2021 Wiley-VCH GmbH.

Entities:  

Keywords:  BAY-876; Glut1; ferroptosis; metabolic inhibition; self-assembly

Year:  2021        PMID: 34350694     DOI: 10.1002/smll.202102695

Source DB:  PubMed          Journal:  Small        ISSN: 1613-6810            Impact factor:   13.281


  5 in total

Review 1.  Glucose Metabolism Intervention-Facilitated Nanomedicine Therapy.

Authors:  Zhiyan Li; Xianghui Li; Shichao Ai; Song Liu; Wenxian Guan
Journal:  Int J Nanomedicine       Date:  2022-06-17

2.  Regulating Acidosis and Relieving Hypoxia by Platelet Membrane-Coated Nanoparticle for Enhancing Tumor Chemotherapy.

Authors:  Xingyu Luo; Jian Cao; Jianming Yu; Dongqing Dai; Wei Jiang; Yahui Feng; Yong Hu
Journal:  Front Bioeng Biotechnol       Date:  2022-05-12

3.  Mitochondrion-targeted supramolecular "nano-boat" simultaneously inhibiting dual energy metabolism for tumor selective and synergistic chemo-radiotherapy.

Authors:  Jie Gao; Zhilong Wang; Qingxiang Guo; Huan Tang; Zhongyan Wang; Cuihong Yang; Huirong Fan; Wenxue Zhang; Chunhua Ren; Jianfeng Liu
Journal:  Theranostics       Date:  2022-01-01       Impact factor: 11.556

4.  Tumor microenvironment-responsive BSA nanocarriers for combined chemo/chemodynamic cancer therapy.

Authors:  Ruiyi Zhang; Teng Liu; Wanzhen Li; Zhiyuan Ma; Pei Pei; Weiwei Zhang; Kai Yang; Yugui Tao
Journal:  J Nanobiotechnology       Date:  2022-05-12       Impact factor: 9.429

Review 5.  Dendrimer-based drug delivery systems: history, challenges, and latest developments.

Authors:  Juan Wang; Boxuan Li; Li Qiu; Xin Qiao; Hu Yang
Journal:  J Biol Eng       Date:  2022-07-25       Impact factor: 6.248

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.